Could bone marrow transplantation cure AIDS?: Review

Medical Hypotheses

Volumn 52, Issue 3, 1999, Pages 247-257

  Huzicka, I ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BABOON; BONE MARROW TRANSPLANTATION; CELL POPULATION; CLINICAL ARTICLE; CONDITIONING; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; XENOTRANSPLANTATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; PAPIO HAMADRYAS;

EID: 0033103135     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1997.0638     Document Type: Article

References (75)

1. Centers for Disease Control. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New york city and california. Morb Mortal Wkly Rep 1982; 31: 507-508; 513-514.
2. Barre-Sinoussi F., Cherman J. C., Rey E. et al. Isolation of a T-lymphotropic from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 1983; 220: 868-871.
3. Gallo R. C., Salahuddin S. Z., Popovic M. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500-503.
4. Wei X., Ghosh S., Taylor M. E. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 273: 117-122.
5. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 273: 123-126.
6. Markowitz M., Saag M., Powderly W. G. et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995; 333: 1534-1539.
7. Collier A. C., Coombs R. W., Schoenfeld D. A. et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trial Group. N Engl J Med 1996; 334: 1011-1017.
8. Pennisi E., Cohen J. Eradicating HIV from a patient: Not just a dream? Science 1996; 272: 1884.
9. Richman D. D. HIV therapeutics. Science 1996; 272: 1886-1888.
10. Editorial. Zidovudine (AZT). Lancet 1987; 1: 957-958.
11. Fauci A. S., Pantaleo G., Stanley S., Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124: 654-663.
12. Bach F. H., Albertini R. J., Joo P. et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968; 2: 1364-1366.
13. Gatti R. A., Allen H. D., Meuwissen H. J., Hong R., Good R. A. Immunological reconstitution of sex-linked lymphopaenic immunological deficiency. Lancet 1968; 2: 1366-1369.
14. Fricker J. Baboon xenotransplant fails but patient improves. Lancet 1996; 347: 457.
15. Culliton B. J. AIDS - A treatable disease at last. Nat Med 1996; 2: 253.
16. Hassett J. M., Zaroulis C. G., Greenbert M. I., Siegal F. P. Bone-marrow transplantation in AIDS. N Engl J Med 1983; 309: 665.
17. Lane H. C., Masur H., Longo D. L. et al. Partial immune reconstituion in a patient with the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 1099-1103.
18. Holland H. K., Saral R., Rossi J. et al. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med 1989; 111: 973-981.
19. Angelucci F., Lucarelli G., Baronciani D. et al. Bone marrow transplantation in an HIV positive thalassemic child following therapy with azidothymidine. Haematologica 1990; 75: 285-287.
20. Aboulafia D. M., Mitsuyasu R. T., Miles S. A. Syngeneic bone-marrow transplantation and failure to eradicate HIV. AIDS 1991; 5: 344.
21. Giri N., Vowels M. R., Ziegler J. B. Failure of allogeneic bone marrow transplantation to benefit HIV infection. J Paediatr Child Health 1992; 28: 331-333.
22. Torlontano G., Di Bartolomeo P., Di Girolamo G. et al. AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin. Haematologica 1992; 77: 287-290.
23. Contu L., La Nasa G., Arras M. et al. Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplant 1993; 12: 669-671.
24. Lane H. C., Zunich K. M., Wilson W. et al. Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection. Ann Intern Med 1990; 113: 512-519.
25. Turner H. L., Watson HG., Russell L., Langlands K., Ludlam C. A., Parker A. C. An HIV positive haemophiliac with acute lymphoblastic leukaemia successfully treated with intensive chemotherapy and syngeneic bone marrow transplantation. Bone Marrow Transplant 1992; 9: 387-389.
26. Klinman D. M., Krieg A., Conover J., Ussery M. A., Black P. L. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS. AIDS Res Hum Retroviruses 1992; 8: 101-106.
27. O'Brien D. R. Eliminating human immunodeficiency virus (HIV) from infected individuals and cells: Is it possible? Med Hypothesis 1992; 38: 20-24.
28. Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993; 262: 1011-1018.
29. Vilmer E., Rhodes-Feuillette A., Rabian C. et al. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation 1987; 44: 25-29.
30. Vilmer E., Vittecoq D., Autran B. et at. Is lymphocyte transfer a promising therapeutic approach towards AIDS? Ann Inst Pasteur Immunol 1987; 138: 269-273.
31. Verdonck L. F., De Gast G. C., Lange J. M., Schuurman H. J., Dekker A. W., Bast B. J. Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation. Blood 1988; 71: 666-671.
32. Riddell S. R., Greenberg P. D., Overell R. W. et al. Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. Hum Gene Ther 1992; 3: 319-338.
33. Hong R. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol 1986; 40: 136-141.
34. Saral R., Holland H. K. Bone marrow transplantation for the acquired immune deficiency syndrome. In: Forman S. J., Blume K. G., Thomas E. D. (eds) Bone Marrow Transplantation. Blackwell Science, Oxford, 1994; pp 654-664.
35. Davis K. C., Hayward A., Öztürk G., Kohler P. F. Lymphocyte transfusion in a case of acquired immunodeficiency syndrome. Lancet 1983; 1: 599-600.
36. Centres for Disease Control. Update on acquired immune deficiency syndrome (AIDS) - United States. Morbid Mortal Weekly Rep 1982; 31: 507-514.
37. Krown S. E., Real F. X., Cunningham-Rundles S. et al. Preliminary observations on the effect of recombinant leukocyte. A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 1983; 308: 1071-1076.
38. Oswald G. A., Theodossi A., Gazzard B. G., Byrom N. A., Fischer-Hoch S. P. Attempted immune stimulation in the 'gay compromise syndrome'. Br Med J Clin Res Ed 1982; 285: 1082.
39. Masur H. The acquired immunodeficiency syndrome. Dis Mon 1983; 30: 1-48.
40. Bortin M. M., Rimm A. A. Severe combined immunodeficienccy disease. Characterization of the disease and results of transplantation. JAMA 1977; 238: 591-600.
41. Gelfand E. W., Dosch H. M. Diagnosis and classification of severe combined immunodeficiency disease. Birth Defects 1983; 19: 65-72.
42. Thomas E. W., Storb R., Clift R. A. et al. Bone marrow transplantation. N Engl J Med 1975; 292: 832-843.
43. Anonymous. Protecting donor marrow from HIV. Lancet 1990; 335: 158.
44. Anonymous. HIV eliminated in AIDS patient with lymphoma. Am Fam Physician 1990; 41: 680.
45. Morse H. C., Yetter R.A., Shearer G. M. Murine models of immunosupression in relation to AIDS. In: Gallo R. C. (ed). HTLV-I, II and III and their Associated Diseases. Martinus Nijhoff, Boston, 1990
46. Ohnota H., Okada Y., Ushijima H., Kitamura T., Komuro K., Mizuochi T. AZT prevents induction of MAIDS in C57/B1/6 mice infected with LP-BM5 leukemia viruses, a possible animal model for antiretroviral drug screening. Antimicrob Agents Chemo 1990; 34: 605-609.
47. Cunningham R. K., Thacore H. R., Zhou P., Terzian R., Nakeeb S., Zaleski M. B. Murine AIDS: A model for the human disease or a distinct entity? Immunol Res 1994; 13: 21-28.
48. Morrow J. W., Homsy J., Eichberg J. W. et al. Long term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment. AIDS Res Hum Retroviruses 1989; 5: 233-245.
49. Allan J. S., Ray P., Broussard S. et al. Infection of baboons with simian/human immunodeficiency viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 429-441.
50. Thompson C. No cheers for baboon to AIDS patient xenotransplant [news]. Lancet 1995; 346: 369-370.
51. Pennisi E. FDA panel OKs baboon marrow transplant [news]. Science 1995; 269: 293-294.
52. Kaufman C. L, Colson Y. L, Wren S. M., Watkins S., Simmons R. L., Ildstad S. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436-2446.
53. Thompson C. No cheers for baboon to AIDS patient xenotransplant. Lancet 1995; 346: 369-370.
54. Taylor R. Baboon graft fails, but patient thrives [news]. Nature Med 1996; 2: 259.
55. Ou C. Y., Kwok S., Mitchell S. W. et al. DNA amplification and detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988 239: 295-297.
56. Burger H., Weiser B., Robinson W. S. et al. Transient antibody to lymphadenopathy-associated virus/human T-lymphocytotropic virus type III and T-lymphocyte abmormalities in the wife of a man who developed acquired immune deficiency syndrome. Ann Intern Med 1985; 103: 565.
57. Burger H., Weiser B. Transient antibody to human immunodeficiency virus. Ann Intern 1986; 105: 464.
58. Farzadegan H., Polis M. A., Wolinsky S. M. et al. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral vinfection in asymptomatic homosexual men. Ann Intern Med 1988; 108: 785-790.
59. Roques P. A., Gras G., Parnet-Mathieu F. et al. Clearance of HIV infection in 12 perinatally infected children: Clinical, virological and immunological data. AIDS 1995; 9: F19-F26.
60. Kenny A. B., Hitzig W. H. Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977. Eur J Pediatr 1979; 131: 285-292.
61. Mathe G. Graft versus host and auto-immune reactions may explain the discontinuity and severity of HIV-1-AIDS disease. Biomed Pharmacother 1994; 48: 1-2.
62. Chigira M. Acquired immune deficiency syndrome caused by hyperimmunity. Med Hypotheses 1996; 46: 489-498.
63. Süsal C., Daniel V., Opelz G. Does AIDS emerge from a disequilibrium between two complementary groups of molecules that mimic MHC? Imm Today 1996; 17: 114-119.
64. Fultz P. N., Schwiebert R. S., Su L., Salter M. M. Effects of total lymphoid irradiation on SIV-infected macaques. AIDS Res Hum Retroviruses 1996; 11: 1517-1527.
65. Andrieu J. M., Lu W. Viro-immunopathogenesis of HIV disease: Implications for therapy. Imm Today 1995; 16: 5-7
66. Horwitz J. P., Chua J. et al. Nucleosides V. The monomesylates of 1-(2′-deoxy-beta-D-lyxofuranoxyl) thymidine. J Organ Chem 1964; 29: 2076-2078.
67. Margolick J. E., Munoz A., Donnenberg A. D. et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Med 1995; 1: 674-680.
68. Haynes B. F. Toword an understanding of the correlates of protective immunity to HIV. Science 1996; 271: 324-328.
69. Borrow P., Lewicki H., Wei X. et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997; 3: 205-211.
70. Goulder P. J. R., Phillips R. E., Colbert R. A. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997; 3: 212-217.
71. Bridges S. H., Sarver N. Gene therapy and immune restoration for HIV disease. Lancet 1995; 345: 427-432.
72. Morgan R. A. Gene therapy for HIV infection. Clin Exp Immunol 1997; 107 Suppl 1: 41-44.
73. Cohen J. T cell shift: Key to AIDS therapy? [Editorial.] Science 1993; 262: 175-176.
74. McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function Science 1988 241: 1632-1639.
75. Ter-Grigorov V. S., Krifuks O., Liubashevsky E., Nyska A., Trainin Z., Toder V. A new transmissible AIDS-like disease in mice induced by alloimmune stimuli. Nature Med 1997; 3: 37-41.